MENU
OZEM
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

OZEM stock forecast, quote, news & analysis

The investment seeks to provide capital appreciation... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
OZEM
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for OZEM with price predictions
Oct 22, 2026

OZEM sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for OZEM moved below the 200-day moving average on September 18, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OZEM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

The Aroon Indicator for OZEM entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where OZEM's RSI Oscillator exited the oversold zone, 19 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.

The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on OZEM as a result. In 26 of 29 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.

The Moving Average Convergence Divergence (MACD) for OZEM just turned positive on October 20, 2026. Looking at past instances where OZEM's MACD turned positive, the stock continued to rise in 21 of 23 cases over the following month. The odds of a continued upward trend are 90%.

Following a +0.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where OZEM advanced for three days, in 140 of 161 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE).

Industry description

The investment seeks to provide capital appreciation. The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.

Market Cap

The average market capitalization across the Roundhill GLP-1 & Weight Loss ETF (OZEM) ETF is 119.25B. The market cap for tickers in the group ranges from 660.11M to 1.13T. LLY holds the highest valuation in this group at 1.13T. The lowest valued company is WVE at 660.11M.

High and low price notable news

The average weekly price growth across all stocks in the Roundhill GLP-1 & Weight Loss ETF (OZEM) ETF was 1%. For the same ETF, the average monthly price growth was -7%, and the average quarterly price growth was -4%. KLRA experienced the highest price growth at 13%, while VKTX experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the Roundhill GLP-1 & Weight Loss ETF (OZEM) ETF was -11%. For the same stocks of the ETF, the average monthly volume growth was -14% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 43
Price Growth Rating: 48
SMR Rating: 76
Profit Risk Rating: 69
Seasonality Score: 22 (-100 ... +100)
OZEM sees its 50-day moving average cross bearishly below its 200-day moving average